Skip to main
RDHL
RDHL logo

RedHill Biopharma (RDHL) Market Capitalization Overview

Market Cap: $4.02M as of Jun 13, 2025

$4.02M
Past Month+$1.71M (73.81%)
As of Jun 13, 2025, RedHill Biopharma (RDHL) has a market capitalization of $4.02M. Over the past 30 days, its market cap has increased by 50.51%, while in the last 12 months, it has decreased by -49.34%.

Market capitalization represents the total value of RedHill Biopharma as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

RedHill Biopharma (RDHL) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of RedHill Biopharma (RDHL) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

RedHill Biopharma (RDHL) Market Cap History

DateMarket CapChange
Jun 2, 2025$4.13M+50.51%
May 1, 2025$2.75M-15.68%
Apr 1, 2025$3.26M-21.78%
Mar 3, 2025$4.16M-44.56%
Feb 3, 2025$7.50M-8.13%
Jan 2, 2025$8.16M-21.86%

RedHill Biopharma (RDHL) End of Year Market Cap History

DateMarket CapChange
2025$4.02M-49.34%
2024$7.92M+37.54%
2023$5.76M-35.95%
2022$8.99M-93.35%
2021$135.20M-56.42%
2020$310.26M

FAQs About RedHill Biopharma (RDHL) Market Cap

As of Jun 13, 2025, the market capitalization of RedHill Biopharma (RDHL) is $4.02M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, RedHill Biopharma’s market capitalization has increased by 73.81%, changing from $2.31M to $4.02M as of Jun 13, 2025.

In the last 3 months, RedHill Biopharma’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, RedHill Biopharma’s market capitalization increased from $5.76M in January to $7.92M in December, reflecting a 37.54% change.

In the past five years, RedHill Biopharma (RDHL) has had a compound annual growth rate (CAGR) of -51.99% in market capitalization. This means its market cap has shrunk at an average rate of -51.99% per year.

RedHill Biopharma (RDHL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.